Poseida Therapeutics FDA Grants Poseida’s P-BCMA-101 Regenerative Medicine Advanced Therapy (RMAT) Status for Treatment of Multiple Myeloma November 19, 2018
Read More
AsclepiX Therapeutics AsclepiX Therapeutics Raises $5M in New Funding Financing will advance clinical development of the Company’s lead product AXT107 November 15, 2018
AsclepiX Therapeutics Baltimore-based AsclepiX Therapeutics raises $5M The Johns Hopkins spinout is developing a new treatment for leading causes of blindness. November 15, 2018
angelMD angelMD Investor Group Closes Funding Round with Indago November 13, 2018
Numat Technologies A Material to Save the World? Metal-organic frameworks are compounds that are set to solve some tough challenges: producing water in the desert, removing greenhouse gases from the…
Poseida Therapeutics BCMA in the spotlight as ASH abstracts drop Updated results from promising CAR-T therapies are expected November 2, 2108
Bellicum Pharmaceuticals, Inc. Bellicum Announces Data Presentations on Lead Product Candidate Rivo-cel and Controllable CAR Program at the 60th American Society of Hematology Annual Meeting November 1, 2018